Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

[3H]-Propranolol Binding Sites in Myocardial Membranes: Nonidentity with Beta Adrenergic Receptors

DOROTHY E. VATNER and ROBERT J. LEFKOWITZ
Molecular Pharmacology May 1974, 10 (3) 450-456;
DOROTHY E. VATNER
Cardiology Division, Department of Medicine, and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT J. LEFKOWITZ
Cardiology Division, Department of Medicine, and Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

[3H]Propranolol binds rapidly and reversibly to sites in membranes prepared from canine ventricular myocardium. Two orders of sites were identified. The higher-order sites have a value (equilibrum constant) of 4.57 x 104 M-1 and a binding capacity of 3.2 x 10-8 mole/ mg of protein. For the lower-order sites K = 4.32 x 102 M-1 and binding capacity is 8.4 x 10-7 mole/mg of protein. Nine adrenergic antagonist drugs were tested for their ability to block [3H]propranolol binding and block isoproterenol activation of adenylate cyclase in dog heart membranes. No clear correlation between the two functions was found. d- and l-Propranolol competed with equal effectiveness for the propranolol binding sites, but l-propranolol was 50 times more potent than the d isomer in blocking cyclase activation. The beta adrenergic blocking agent dichloroisoproterenol was a very weak inhibitor of [3H]-propranolol binding. Chlorpromazine and haloperidol inhibited both propranolol binding and cyclase activation. It is concluded that the [3H]propranolol binding sites studied here are unrelated to the myocardial beta adrenergic receptors and may be involved in mediating the more general membrane or local anesthetic effects of propranolol. Beta adrenergic receptor binding sites presumably represent too small a fraction of myocardial membrane sites capable of binding propranolol to be revealed by binding studies of this type.

ACKNOWLEDGMENT The authors are indebted to Dr. Edgar Harber, Massachusetts General Hospital, in whose laboratory part of these studies were performed.

  • Copyright ©, 1974, by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 10, Issue 3
1 May 1974
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
[3H]-Propranolol Binding Sites in Myocardial Membranes: Nonidentity with Beta Adrenergic Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

[3H]-Propranolol Binding Sites in Myocardial Membranes: Nonidentity with Beta Adrenergic Receptors

DOROTHY E. VATNER and ROBERT J. LEFKOWITZ
Molecular Pharmacology May 1, 1974, 10 (3) 450-456;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

[3H]-Propranolol Binding Sites in Myocardial Membranes: Nonidentity with Beta Adrenergic Receptors

DOROTHY E. VATNER and ROBERT J. LEFKOWITZ
Molecular Pharmacology May 1, 1974, 10 (3) 450-456;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics